DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Ottmann O, Saglio G, Apperley JF. et al.
Long-term efficacy and safety of dasatinib in patients with chronic myeloid leukemia in accelerated phase who are resistant to or intolerant of imatinib.
Blood Cancer J 2018;
8 (09) 88
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.